Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China

• Main Authors: Haitao Zhang (Author), Jingyuan Xie (Author), Chuanming Hao (Author), Xuemei Li (Author), Dalong Zhu (Author), Hongguang Zheng (Author), Xudong Xu (Author), Zhaohui Mo (Author), Weiping Lu (Author), Yibing Lu (Author), Chaoqing Wu (Author), Nanwei Tong (Author), Li Wang (Author), Zhihong Liu (Author)
• Format: Book
• Published: Karger Publishers, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: This prespecified subgroup analysis of the FIDELIO-DKD trial aimed to evaluate the efficacy and safety of finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) in China. Methods: 372 participants were recruited from 67 centers in China and randomize...